Showing results (11-20 of 112) with videos related to
Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry|December 16, 2004
Synthesis and antiproliferative activity of [1,2,3,5]tetrazino[5,4-a]indoles, a new class of azolo-tetrazinonesPaola Barraja, Patrizia Diana, Antonino Lauria, et al.Anticancer Research|March 2, 2005
Synthesis and antiproliferative activity of [1,2,4]triazino [4,3-a] indolesPaola Barraja, Patrizia Diana, Antonino Lauria, et al.Bioorganic & Medicinal Chemistry|May 9, 2003
Pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3H)-ones, a new class of azolotetrazines with potent antitumor activityPatrizia Diana, Paola Barraja, Antonino Lauria, et al.European Journal of Medicinal Chemistry|March 20, 2002
Pyrrolo[2,1-c][1,2,4]triazines from 2-diazopyrroles: synthesis and antiproliferative activityPatrizia Diana, Paola Barraja, Antonino Lauria, et al.Expert Opinion on Investigational Drugs|October 22, 2024
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancerEmma Geijerman, Francesca Terrana, Godefridus J Peters, et al.Current Computer-Aided Drug Design|January 26, 2017
Investigation of Isoindolo[2,1-a]quinoxaline-6-imines as Topoisomerase I Inhibitors with Molecular Modeling MethodsBalazs Balogh, Anna Carbone, Virginia Spanò, et al.Bioorganic & Medicinal Chemistry|September 22, 2006
Pyrrolo[2,3-h]quinolinones: a new ring system with potent photoantiproliferative activityPaola Barraja, Patrizia Diana, Alessandra Montalbano, et al.Future Medicinal Chemistry|January 25, 2024
Exploring the therapeutic potential of focal adhesion kinase inhibition in overcoming chemoresistance in pancreatic ductal adenocarcinomaFabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.European Journal of Medicinal Chemistry|October 20, 2017
1,3,5-Triazines: A promising scaffold for anticancer drugs developmentStella Cascioferro, Barbara Parrino, Virginia Spanò, et al.Organic & Biomolecular Chemistry|September 16, 2021
Synthesis and pharmacological evaluation of enantiomerically pure endo-configured KOR agonists with 2-azabicyclo[3.2.1]octane scaffoldHendrik Jonas, Daniele Aiello, Bastian Frehland, et al.Pageof 12